Clinical trial
REINFORCE - Reducing Infection-related Readmissions Following Cystectomy. a Multicentre Randomised Clinical Trial Testing Superiority of Individualised Targeted Antibiotic Prophylaxis Over Empiric Prophylaxis At Ureteral Stent Removal to Reduce Infection-related Readmissions Following Cystectomy.
NCT06709196 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REINFORCE - Reducing Infection-related Readmissions Following Cystectomy. a Multicentre Randomised Clinical Trial Testing Superiority of Individualised Targeted Antibiotic Prophylaxis Over Empiric Prophylaxis At Ureteral Stent Removal to Reduce Infection-related Readmissions Following Cystectomy.
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 7, 2025
- Completion date
- January 31, 2027
- Enrollment
- 248 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
antibiotic prophylaxis, bladder cancer requiring cystectomy, cystectomy, ileal conduit, postoperative infections